Vijay Sabesan
2020
Compensation breakdown
Non-Equity Incentive Plan | $760,326 |
---|---|
Salary | $407,677 |
Stock Awards | $1,903,200 |
Other | $6,541 |
Total | $3,077,744 |
Sabesan received $1.9M in stock awards, accounting for 62% of the total pay in 2020.
Sabesan also received $760.3K in non-equity incentive plan, $407.7K in salary and $6.5K in other compensation.
Rankings
In 2020, Vijay Sabesan's compensation ranked 3,771st out of 13,090 executives tracked by ExecPay. In other words, Sabesan earned more than 71.2% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 3,771 out of 13,090 | 71st |
Division Manufacturing | 1,494 out of 5,624 | 73rd |
Major group Chemicals And Allied Products | 562 out of 2,257 | 75th |
Industry group Drugs | 485 out of 1,957 | 75th |
Industry Pharmaceutical Preparations | 366 out of 1,462 | 75th |
Pay ratio
Vijay Sabesan's Pay | $3,077,744 |
---|---|
Median Employee's Pay | $269,883 |
Pay Ratio | 11to 1 |
In 2020, the annual total compensation of Vijay Sabesan was $3,077,744.
The annual total compensation of the median employee at Theravance Biopharma was $269,883.
The ratio of Vijay Sabesan's pay to the pay of median employee was therefore 11 to one.
Sabesan's colleagues
We found four more compensation records of executives who worked with Vijay Sabesan at Theravance Biopharma in 2020.